Assyro AI
US FDAUnited StatesCRLComplete Response Letter

Complete Response Letter NDA 505b1 217556 (Feb 22, 2024)

Issued February 22, 2024

Issued

February 22, 2024

Application

NDA 505b1 • 217556

Review center

CDER

Stage

Final Decision

Letter type

Complete Response Letter

Response due February 21, 2025Requires resubmission addressing deficiencies.

Document viewer

Read the FDA letter and send context to the co-pilot at any time.

Loading PDF…